NJ Hospital Cures Sickle Cell Without a Donor Match

Gerald Quartey is living a miracle that once seemed impossible: he's cured of sickle cell disease without needing a donor.

The Penn State freshman received groundbreaking gene therapy at Hackensack University Medical Center, becoming the first patient in New Jersey treated with Lyfgenia. The one-time treatment uses a patient's own stem cells, genetically modified to cure the disease.

For his mother Evelyn, whose older son died from sickle cell, the cure answered two decades of prayers. She calls it the ultimate Mother's Day gift.

The timing carries special meaning as March Madness spotlights Duke freshmen Cameron and Cayden Boozer, twin brothers born specifically to save their older sibling Carmani from sickle cell. Their cord blood provided the perfect genetic match for a traditional bone marrow transplant that cured him in 2008.

That approach has been the gold standard for over 20 years, but it requires finding a matching sibling donor. Many families don't have that option.

"A bone marrow transplant from a matched sibling has been the gold standard and a true miracle for families," said Dr. Christine Camacho-Bydume, a pediatric hematologist-oncologist at Hackensack. "Our program's experience in performing these complex transplants is the foundation upon which new gene therapies are built."

Hackensack Meridian Health has performed donor-based transplants for more than two decades. Now they're pioneering the donor-free future as a New Jersey Qualified Treatment Center for Lyfgenia.

The Ripple Effect

The FDA-approved therapy represents more than individual healing. It opens the door for countless patients who previously had no cure because they lacked a family match.

Dr. Stacey Rifkin-Zenenberg captures the transformation: "We are no longer limited. We now have multiple ways to achieve the same goal: giving a child a life free from sickle cell disease."

While the Boozer twins chase a national championship, Gerald's victory happened off the court. His cure required no siblings, no perfect match, just cutting-edge science meeting decades of transplant expertise.

For families watching their children suffer from sickle cell disease, the message is clear: hope just multiplied.